Patents by Inventor Jonathan Gawn

Jonathan Gawn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7501129
    Abstract: The invention comprises novel polynucleotides, and related vectors, host cells, methods, and compositions, containing transcriptional enhancers providing very high levels of expression of operably-linked expressible nucleic acid sequences in eukaryotic cells. Advantageously the enhancers may be used in combination with their naturally-associated promoters and/or other genetic elements that increase transcription. The invention comprises eukaryotic expression vectors that are capable of providing increased levels of expression in many cell types over that obtainable from human or murine CMV IE enhancer/promoter elements.
    Type: Grant
    Filed: March 3, 2006
    Date of Patent: March 10, 2009
    Assignee: Millipore Corporation
    Inventors: Steven Geraint Williams, Alistair Simpson Irvine, Jonathan Gawn
  • Publication number: 20060223772
    Abstract: The invention comprises novel polynucleotides, and related vectors, host cells, methods, and compositions, containing transcriptional enhancers providing very high levels of expression of operably-linked expressible nucleic acid sequences in eukaryotic cells. Advantageously the enhancers may be used in combination with their naturally-associated promoters and/or other genetic elements that increase transcription. The invention comprises eukaryotic expression vectors that are capable of providing increased levels of expression in many cell types over that obtainable from human or murine CMV IE enhancer/promoter elements.
    Type: Application
    Filed: March 3, 2006
    Publication date: October 5, 2006
    Inventors: Steven Williams, Alistair Irvine, Jonathan Gawn